Harshal Broker, MD
Vascular Surgery · Fort Worth, TXNPI 1245434034
Payments from drug & device makers
Across 143 payments — averaging $58.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$3K
- Bolton Medical Inc$866
- Abbott$823
- W. L. Gore & Associates, Inc.$601
- Silk Road Medical, Inc.$403
- Endologix LLC$396
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$2,40029%
- Food & beverage$5,94071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 19 | $3,092 |
| Bolton Medical Inc | 13 | $866 |
| Abbott | 23 | $823 |
| W. L. Gore & Associates, Inc. | 14 | $601 |
| Silk Road Medical, Inc. | 17 | $403 |
| Endologix LLC | 5 | $396 |
| Penumbra, Inc. | 3 | $365 |
| Biotronik Inc. | 14 | $237 |
| Cagent Vascular Inc | 1 | $189 |
| Cook Medical LLC | 6 | $179 |
| Shockwave Medical, Inc | 2 | $169 |
| Reflow Medical Inc | 4 | $148 |
| Terumo BCT, Inc. | 1 | $141 |
| Globus Medical | 1 | $128 |
| Cook Incorporated | 1 | $117 |
| Medtronic | 2 | $84 |
| Boston Scientific | 3 | $80 |
| Angiodynamics, Inc. | 3 | $60 |
| Johnson & Johnson | 2 | $48 |
| Organogenesis Inc. | 1 | $46 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Lemaitre Vascular, Inc. | 1 | $28 |
| Davol Inc. | 1 | $27 |
| Innovation Technologies Inc | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $20 |
| Acera Surgical, Inc. | 1 | $18 |
| Artivion, Inc. | 1 | $17 |
| Flowphysix Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spectranetics Undiv$2,400
- Alto Abdominal Stent Graft System$328
- TREO ABDOMINAL STENT-GRAFT SYSTEM$298
- RUBY Coil$222
- ESPRIT$217
- Serrantor$189
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$158
- GORE PROPATEN Vascular Graft$149
- Indigo System$144
- Grafts$143
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$142
- HARVEST BMAC$141
- ENROUTE Transcarotid Neuroprotection System$132
- ENROUTE Transcarotid Stent$132
- Retrieve$128
- (BS0) Mechanical Atherectomy$127
- Passeo-18$125
- Pulsar-18 T3$125
- (4067) Tack Endo Sys BTK$124
- Zilver PTX$123
How this compares
$8,340 in reported general payments places this provider in the 50th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 25 | $30,040 |
| EliquisApixaban | 24 | $14,361 |
| ClopidogrelClopidogrel Bisulfate | 257 | $2,199 |
| Cilostazol | 14 | $188 |
| Tramadol Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $48 | $30,04025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Fort Worth
- Katherine KaneFort Worth$149K
- Johnna JonesFort Worth$90K
- Atish ChopraFort Worth$55K
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.